Claire Barton - Concepedia

Author

Claire Barton

Hammersmith Hospital ORCID

Also Known As

C Barton, C. BARTON, C. Barton, C.M. Barton, Claire Barton, Claire M. Barton, Connor Barton

Publications

Citations

H-Index

Concepts

All Affiliations

Hammersmith Hospital Cancer Research UK King's College London Guy's and St Thomas' NHS Foundation Trust Fondazione IRCCS Istituto Nazionale dei Tumori

About

Claire Barton is an author at Hammersmith Hospital specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	14	2.3K
2	Engineering	2	2	187
3	Health Sciences	2	2	1.3K
4	Allergy	1	1	18
5	Biochemistry	1	1	18

Claire Barton

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort Luca Gianni, W. Eiermann, Alexey Manikhas, The Lancet Noah TrialBreast OncologyOncologyClinical TrialsBreast Cancer	2010	1.2K
Phase II Study of Efficacy, Safety, and Pharmacokinetics of Trastuzumab Monotherapy Administered on a 3-Weekly Schedule José Baselga, Xavier Carbonell, Noel-Jaime Castañeda-Soto, Journal of Clinical Oncology	2005	425
Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer U. Gatzemeier, G. Groth, Charles Butts, Annals of Oncology Phase Ii TrialMedicineMetronomic TherapyPathologyCancer Treatment	2003	383
The epidermal growth factor receptor in human pancreatic cancer Nicholas R. Lemoine, Christine M. Hughes, Claire Barton, The Journal of Pathology Epidermal Growth FactorPancreatic CancerHistopathologyCancer GrowthPathology	1992	212
Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer Claire Barton, Peter A. Hall, Christine M. Hughes, The Journal of Pathology	1991	211
Antitumor activity without on-target off-tumor toxicity of GD2–chimeric antigen receptor T cells in patients with neuroblastoma Karin Straathof, Barry Flutter, Rebecca Wallace, Science Translational Medicine	2020	195
Activating point mutations of the <i>gsp</i> oncogene in human thyroid adenomas Catriona O’Sullivan, Claire Barton, S Staddon, Molecular Carcinogenesis EngineeringHuman GrowthGeneticsPathologyHuman Thyroid Adenomas	1991	169
Randomized Phase II Trial of First-Line Trastuzumab Plus Docetaxel and Capecitabine Compared With Trastuzumab Plus Docetaxel in <i>HER2</i>-Positive Metastatic Breast Cancer Andrew Wardley, Xavier Pivot, Flavia Morales-Vásquez, Journal of Clinical Oncology	2009	118
The <i>erbB‐3</i> Gene in human pancreatic cancer Nicholas R. Lemoine, Maria Lobresco, Hing Y. Leung, The Journal of Pathology	1992	92
Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling Debra H. Josephs, Heather J. Bax, Tihomir Dodev, Cancer Research	2017	77

Page 1